Ted Buchan & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.91M | Buy |
3,727
+1,227
| +49% | +$956K | 1.16% | 26 |
|
|
2025
Q1 | $2.06M | Buy |
2,500
+51
| +2% | +$42.1K | 0.98% | 28 |
|
|
2024
Q4 | $1.89M | Buy |
2,449
+313
| +15% | +$242K | 0.89% | 28 |
|
|
2024
Q3 | $1.89M | Buy |
2,136
+170
| +9% | +$151K | 0.9% | 28 |
|
|
2024
Q2 | $1.78M | Buy |
1,966
+95
| +5% | +$86K | 0.95% | 25 |
|
|
2024
Q1 | $1.46M | Buy |
1,871
+251
| +15% | +$195K | 0.89% | 26 |
|
|
2023
Q4 | $944K | Sell |
1,620
-103
| -6% | -$60K | 0.69% | 33 |
|
|
2023
Q3 | $925K | Buy |
1,723
+40
| +2% | +$21.5K | 0.74% | 27 |
|
|
2023
Q2 | $789K | Sell |
1,683
-106
| -6% | -$49.7K | 0.61% | 40 |
|
|
2023
Q1 | $614K | Buy |
1,789
+186
| +12% | +$63.9K | 0.51% | 44 |
|
|
2022
Q4 | $586K | Buy |
+1,603
| New | +$586K | 0.54% | 47 |
|